Mark Rothera - Insider Trading & Ownership

Entity
Individual
Location
C/O Aegerion Pharmaceuticals, Inc., 101 Main Street, Suite 1850, Cambridge, MA
Summary
The estimated net worth of Mark Rothera is at least $49.3K dollars as of March 13, 2024. Mark Rothera is the President and CEO, Director of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $49.3K.
All Insider Reports
All Insider Reports

Ownership of Mark Rothera

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VIRX Viracta Therapeutics, Inc. President and CEO, Director $49.3K Mar 12, 2024

Insider Transactions Reported by Mark Rothera:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.